Literature DB >> 29116640

Strain Diversity and the Evolution of Antibiotic Resistance.

Sonia Borrell1,2, Andrej Trauner3,4.   

Abstract

Drug resistance is best thought of as an ongoing biological process. Resistant bacteria must emerge, become established and ultimately transmit in order to be relevant to human health. In this context, genetic diversity can influence the rate and likelihood of resistance emerging; it can also modulate the net physiological impact of resistance and the propensity of an organism to improve any defects that arise from it. Combined, these effects can have an impact on a larger scale, with highly transmissible drug-resistant bacterial strains posing a formidable threat to global health. These considerations are pertinent to the future of tuberculosis control as well. In this chapter, we review our current understanding of the impact of genetic diversity in the broadest sense on the evolution of drug-resistant members of the Mycobacterium tuberculosis complex.

Entities:  

Keywords:  Drug resistance; Epistasis; Evolution; Fitness Landscape

Mesh:

Substances:

Year:  2017        PMID: 29116640     DOI: 10.1007/978-3-319-64371-7_14

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

1.  Sex and age differences in Mycobacterium tuberculosis infection in Brazil.

Authors:  P Fernandes; Y Ma; M Gaeddert; T Tsacogianis; P Marques-Rodrigues; G Fregona; A Loomans; E C Jones-López; R Dietze; J J Ellner; L F White; N S Hochberg
Journal:  Epidemiol Infect       Date:  2018-06-08       Impact factor: 4.434

2.  Structural, functional and biological insights into the role of Mycobacterium tuberculosis VapBC11 toxin-antitoxin system: targeting a tRNase to tackle mycobacterial adaptation.

Authors:  Amar Deep; Prabhakar Tiwari; Sakshi Agarwal; Soni Kaundal; Saqib Kidwai; Ramandeep Singh; Krishan G Thakur
Journal:  Nucleic Acids Res       Date:  2018-11-30       Impact factor: 16.971

3.  Antimicrobial use and resistance in Escherichia coli from healthy food-producing animals in Guadeloupe.

Authors:  Gaëlle Gruel; Arantxa Sellin; Hélène Riveiro; Matthieu Pot; Sébastien Breurec; Stéphanie Guyomard-Rabenirina; Antoine Talarmin; Séverine Ferdinand
Journal:  BMC Vet Res       Date:  2021-03-08       Impact factor: 2.741

4.  LytU-SH3b fusion protein as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus.

Authors:  Mortaza Taheri-Anganeh; Seyyed Hossein Khatami; Zeinab Jamali; Ahmad Movahedpour; Younes Ghasemi; Amir Savardashtaki; Zohreh Mostafavi-Pour
Journal:  Mol Biol Res Commun       Date:  2019-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.